key: cord-0855066-08nscpu4
authors: Eid, Ragaey A.; Attia, Abdelrahman M.; Hassan, Mahmoud; Shaker, Marwa Abdallah; Kamal, Manar Ahmed
title: Demographic, Clinical, and Laboratory Characteristics of Patients with COVID-19 During the Second and Third Waves of the Pandemic in Egypt
date: 2021-08-14
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2021.08.009
sha: fd1cf2e668e121d11059f84e23d932ac61f4e483
doc_id: 855066
cord_uid: 08nscpu4

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus that belongs to the coronaviruses and causes coronavirus disease 2019 (COVID-19). In this study, we explored the demographic details, clinical features, and routinely conducted laboratory investigations of patients with COVID-19 during the second and third waves of the pandemic to understand their possible diagnostic and prognostic values in Egypt. METHODS: In this retrospective cohort study, the demographic characteristics, detailed medical history, laboratory findings, and symptoms of all enrolled patients with SARS-CoV-2 were collected from the medical records of Beni Suef University Hospitals between December 15, 2020, and April 15, 2021. RESULTS: This retrospective study included 473 patients, almost all of whom were elderly. The median age of the patients was 48 years, and those with moderate and severe disease were older than those with mild infections. The proportion of females was higher (63.4%) than males (36.6%). Diabetes mellitus (DM) was the most common comorbidity (17.3%), and fever was the most typical manifestation of COVID-19 (62.6%). Those with severe disease showed a higher C-reactive protein level (CRP) than those with moderate (p-value 0.009) or mild (p-value 0.01) diseases. Serum ferritin levels were significantly higher in patients with severe disease than in those with moderate disease (p-value 0.018). In contrast, D-dimer and serum creatinine were normal and showed no significant difference in all comparisons (p-value overall 0.21). CONCLUSION: This study observed several variations in COVID-19 patients’ characteristics. The new manifestations included skin rash, bone and low back pains, and rigors. In contrast to females, most males had moderate-to-severe illness. Old age and higher body mass index was associated with increasing severity. D-dimer and complete blood count were normal and could not identify potential COVID‐19 patients. Patients who had mild illness were still at risk of developing post-COVID complications.

variable and disease severity. Patients were classified into mild, moderate, and severe disease groups. Patients were classified into mild, moderate, and severe disease groups. The main statistical test is Post hoc power analysis: alpha = 0.01, total sample size = 473, effect size = 0.30 (see Supplementary Figure 1 ).

We included patients admitted to the hospitals between December 15, 2020, and April 15, 2021 . Patients were diagnosed according to the WHO interim guidance based on a SARS-CoV-2-positive nasopharyngeal swab by RT-PCR. We included patients aged ≥18 from both the sexes with mild, moderate, and severe COVID-19.

Patients with missing data were transferred to other medical facilities with unknown outcomes and those aged <18 years old were excluded.

Demographic characteristics, detailed medical history, laboratory findings, and symptoms of all enrolled patients positive for SARS-CoV-2 infection were collected from the medical records of hospitals between December 15, 2020, and April 15, 2021 . We handled and managed the data in a spreadsheet before starting the analysis.

Data on demographic characteristics, previous medical history, and laboratory findings, including hematologic and biochemical parameters (complete blood count [CBC] , liver function tests, kidney function test, C-reactive protein [CRP] , fasting blood glucose, ferritin, and D-dimer), were collected. The diagnosis of COVID-19 was based J o u r n a l P r e -p r o o f on the history of epidemiologic exposure and clinical manifestations. The diagnosis was confirmed when positive results were obtained on performing SARS-CoV-2 RT-PCR test (see Supplementary Table 1) . According to the COVID-19 protocol of the Egyptian Ministry of Health [22] , [23] , the primary treatment for mild, moderate, and severe cases are based on antiviral drugs, immune modulators, anti-inflammatory drugs, analgesics, and multivitamins (see Appendix 1). After the patients were discharged from the hospital, their mean follow-up duration was approximately 13.5 days, which changed according to the patients' severity of disease.

The collected data were summarized and presented using suitable tables and graphs.

Continuous nonnormally distributed variables are presented as median and interquartile range, and categorical variables are presented as numbers and percentages. Statistical significance was evaluated using the Kruskal-Wallis test for continuous variables and a chi-square test (χ²) or Fisher's exact test for categorical variables as appropriate. We performed post hoc pairwise comparisons among groups using the Bonferroni adjustment method after significant effects have been found. The association between the variables was tested using Spearman correlation analysis, followed by multinomial logistic regression analysis, including all factors showing significance (p < 0.05). Multinomial logistic regression models were conducted to determine the association between the predictor and dependent variables. The optimal CRP cutoff point was evaluated using the receiver operator characteristic (ROC) curve. The dependent variable (severity grade) was classified as J o u r n a l P r e -p r o o f 8 mild (reference category), moderate, or severe. Therefore, the multinomial regression model was used to compare mild vs. moderate and mild vs. severe disease probabilities. A p-value of ≤0.05 was considered statistically significant. We conducted statistical analyses using the Statistical Package for the Social Sciences (SPSS) software (version 26.0) [24] .

This study was an observational cohort study that recruited human participants and thus conducted according to the ethical principles of the Declaration of Helsinki. The study was ethically approved by the ethical research committee of the Faculty of Medicine, Beni Suef University, Beni Suef, Egypt (ethical approval number: FMBSUREC/09052021/Eid) (see Supplementary Figure 2 ). In addition, informed oral consent was obtained from the patients or relatives for their medical reports.

J o u r n a l P r e -p r o o f

This retrospective study included 476 patients. Three patients were excluded: two with inadequate data in their hospital records and <18 years old. Almost all patients were older, and the median age was 48 years old. Patients with moderate and severe disease were older than those with mild disease. The proportion of females was higher (63.4%) than males (36.6%). However, males developed moderate and severe illnesses more frequently than did females. Approximately 8.5% of the patients were smokers. Diabetes mellitus (DM) was the most common comorbidity (17.3%), followed by hypertension (HTN) (16.7%) and hepatitis C virus (HCV) (7.5%). The most common clinical manifestations of COVID-19 were fever (62.6%), followed by cough (52.7%), bony pain (39.8%), dyspnea (36%), rigors (27.3%), and abdominal pain (26.8%). All baseline demographic and clinical characteristics are listed in Table 1 .

The hematologic and coagulation parameters are presented in Table 2 . Neutrophil count, lymphocyte count, neutrophil/lymphocyte (N/L) ratio, CRP, alanine aminotransferase (ALT), aspartate aminotransferase (AST), platelet, fasting blood sugar (FBS), and serum ferritin (all p < 0.001) and monocyte (p < 0.05) were significantly different in all comparisons.

Regarding the laboratory findings in Table 2 , the patients with severe infection showed significantly higher CRP than those with moderate and mild illness. Serum ferritin was significantly higher in patients with severe disease than in those with J o u r n a l P r e -p r o o f moderate disease (mainly males) (see Figure 1) , and FBS was also considerably higher in patients with severe disease than those with moderate and mild illness.

Basal O2 was significantly lower in patients with severe disease (p < 0.001), while heart rate was considerably higher in patients with severe disease (p < 0.001) (see Table 2 ).

The optimum cutoff value for CRP to predict severe disease was 17.4 mg/L using a ROC curve with a sensitivity of 76.4% and a specificity of 63.4%. The area under the ROC curve (AUC) for severe cases was 0.73 (see Figure 2 ). The accuracy of D-dimer to diagnose was poor (AUC = 0.56) with a cutoff value (0.77) , and the accuracy of serum ferritin to diagnose severe cases was fair (AUC = 0.75) with a cutoff value (165.86), and they were at the normal range; this means that there were severe cases with normal serum ferritin and normal D-dimer.

A low positive correlation was noted between body mass index (BMI), sex, DM, HTN, ischemic heart disease, HCV, liver cirrhosis, chronic kidney disease (CKD), cough, sweating, ALT, AST, FBS, segmented neutrophils %, N/L ratio, heart rate, and grade of severity. A low negative correlation was noted between diarrhea, abdominal pain, anosmia, dysgeusia, rhinorrhea, platelet, lymphocyte percentage (%), and grade of severity as well as the association between the grade of severity. A moderately positive correlation was established between age, serum ferritin, CRP, duration of O2 treatment per day, time of follow-up per day, and grade of severity (see Table 3 ). All J o u r n a l P r e -p r o o f factors showing significance (p < 0.05) were evaluated using the multinomial logistic regression model (see Table 4 ).

The multinomial regression analysis revealed that age, BMI, sex, DM, HTN, HCV, liver cirrhosis, CKD, diarrhea, abdominal pain, anosmia, dysgeusia, cough, rhinorrhea, sweating, ALT, AST, CRP, FBS, serum ferritin, segmented %, lymphocyte %, N/L ratio, basal O2, and heart rate were significant predictors of severe grade (see Table 4 ).

The odds ratio (OR) for age was 1.07 (95% confidence interval [CI], 1.05-1.08), meaning that older patients had a higher chance of developing the more severe disease than younger patients. The OR for BMI was 1.2 (95% CI, 1.12-1.3), meaning that patients with higher BMI had a higher chance of developing more severe disease than patients with lower BMI. The OR of female patients was 0.48 (95% CI, 0.28-0.82), meaning that female patients had a lesser chance of developing severe symptoms than male patients. The OR for DM, HTN, HCV, liver cirrhosis, and CKD were 0.13 (95% CI, 0.07-0.25), 0.15 (95% CI, 0.07-0.29), 0.10 (95% CI, 0.04-0.27), 0.11 (95% CI, 0.028-0.44), and 0.09 (95% CI, 0.009-0.89), respectively, meaning that patients without these comorbidities had a lesser chance of developing more severe disease than patients with these comorbidities. The OR for diarrhea, abdominal pain, anosmia, dysgeusia, and rhinorrhea were 2.47 (95% CI, 1. 16 respectively, meaning that patients without these symptoms had a lower chance of developing more severe disease than patients with these symptoms. Those patients J o u r n a l P r e -p r o o f with symptoms such as cough (OR, 0.44; 95% CI, 0.25-0.75) and sweating (OR, 0.29; 95% CI, 0.11-0.76) had a lower chance of developing more severe disease than those without these symptoms. The OR for laboratory findings ALT, AST, FBS, CRP, serum ferritin, segmented %, and N/L ratio were 1.16 (95% CI, 1.10-1.24), 1.15 (95% CI, 1.09-1.21), 1.012 (95% CI, 1.008-1.017), 1.022 (95% CI, 1.015-1.029), 1.006 (95% CI, 1.004-1.008), 1.05 (95% CI, 1.02-1.07), and 1.28 (95% CI, 1.13-1.45), respectively, meaning that patients with higher laboratory findings had a higher chance of developing more severe disease than those with lower laboratory findings. The OR for lymphocyte percentage was 0.95 (95% CI, 0.92-0.97), meaning that those patients with a higher lymphocyte percentage had a lesser chance of developing more severe disease than those with a lower lymphocyte percentage.

The OR for basal O2 was 0.98 (95% CI, 0.97-0.99), meaning that patients with higher basal O2 had a lesser chance of developing more severe disease than lower basal O2.

The OR for heart rate was 1.05 (95% CI, 1.03-1.08), meaning that patients with a higher heart rate had a higher chance of developing more severe disease than those with a lower heart rate.

Six death events occurred during hospitalization; all six patients (100%) had severe disease. In addition, clinical follow-up complications, such as deep vein thrombosis (DVT), appeared in one patient (0.2%) with severe illness after hospital discharge despite oral anticoagulation therapy. Moreover, persistent polyneuropathic pain appeared in one patient (0.2%) with mild disease, chronic cough appeared in three J o u r n a l P r e -p r o o f COVID-19 emerged in December 2019 in Wuhan. Unfortunately, the published data from Egypt currently only present the patient characteristics of the first wave of the pandemic. Therefore, the disease characteristics, severity, mortality, risk factors, and associated comorbidities remain unclear [25] , especially in Egypt. The current study examined the disease characteristics during the second and third waves of the pandemic.

The current study revealed that patients with moderate and severe COVID-19 were older than those with mild COVID-19. In agreement with our findings, Liao et al. [19] , Ghweil et al. [4] , and Liu et al. [26] reported that elderly patients with COVID-19 were more likely to have acute and severe COVID-19 compared with middle-aged people with COVID-19. This age-dependent variation in the severity of COVID-19 could be explained by decreased cell-mediated immune function and reduced humoral immune function [27] . The proportion of infected females was higher than infected males, which agrees with the findings of two previous studies [28] , [29] . Two previous studies presented results on sex-specific differences in the severity of COVID-19, which were similar to our work; almost all of the previous work has demonstrated that the number of infected males was higher than that of the infected females [4], [19] , [30] - [33] . However, the percentage of females was higher, but males developed moderate and severe illness more frequently than females, which is in agreement with the findings of the present study and the previous literature[4], [19] , [30] - [33] .

Approximately 8.5% of the patients were smokers, and smoking has been previously related to higher expression of angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 [34] . A previous systematic review that included five studies reported that smoking is most likely associated with the negative progression and adverse outcomes of COVID-19 [35] .

In contrast, the results of our study showed no association between smoking and COVID-19 severity. Our study reported that the incidence of SARS-CoV-2 infection was associated with underlying comorbidities, the most common of which was DM, followed by HTN, as described in most previous literature [4], [19] , [28] - [30] , [36] , [37] . In line with our findings, Marhl et al. [38] reported a higher risk of COVID-19 among patients with diabetes due to the association between the dysregulation of ACE2. The higher risk of COVID-19 among patients with diabetes physiologically maybe because of liver dysfunction and chronic inflammation [38] . In addition, Singh et al. [39] reported that the incidence rate and severity of COVID-19 increased in patients with diabetes.

Moreover, the majority of joint clinical presentations of COVID-19 were fever, followed by cough, as identified in our study and previous studies {Formatting Citation}. Skin rash was the slightest common manifestation of COVID-19, and dermatological manifestations have been increasingly reported in the last few months [40] , [41] . Our laboratory findings showed that CRP and serum ferritin levels were significantly higher in patients with severe disease than in those with moderate disease, which is in agreement with the results of previous studies [4], [28] , [30] , [37] .

These findings can be explained because CRP is an acute-phase protein that serves as an early marker of COVID-19 infection [42] . The optimum cutoff value for CRP to predict severe disease was 17.4 mg/L using the ROC curve with a sensitivity of 76.4% and a specificity of 63.4%. The AUC for the painful condition was 0.73. Indeed, a pooled analysis of more than ten studies showed that non-survivors with COVID-19 had a significantly higher ferritin level than survivors with COVID-19 [43] . D-dimer, serum creatinine, lymphocyte count, platelet count, staff neutrophils, segmented neutrophils, lymphocytes, monocytes, eosinophils, and basophils, on the other hand, were normal and not significantly different across all comparisons.

Moreover, the N/L ratio was standard, which agrees with the findings of Fan et al. [31] , which reported that most patients had a standard CBC test. Only patients with severe disease had death events, and approximately six hospitalized patients with severe illnesses died. The survivors of severe disease complained of DVT, chronic cough, and chronic fatigue, and some had to remain under supervision in the intensive care unit.

The strengths of our study are its large sample, as we include 473 patients and the fact that our research is the first to discuss the demographic, clinical characteristics and routine laboratory investigations of patients with COVID-19 during the second and third waves of the pandemic in Egypt. The main limitation of this study is the potential for selection bias given its single-center nature and the missing data as some results of laboratory investigations of some patients.

In conclusion, we observed many variations in COVID-19 patients' characteristics.

Regarding the clinical features, fever remained the most common symptom as in the first wave. The new manifestations included skin rash, bony pain, low back pain, and rigors. In particular, the number of females was higher than the number of males; however, most males had a moderate and severe illness, which contrasted with females. Old age, higher BMI was associated with increasing severity. The subjects diagnosed with DM, HTN, HCV, liver cirrhosis, and CKD tended to have higher disease severity. The severity of COVID-19 can be suggested to be associated with ALT, AST, FBS, CRP, serum ferritin, segmented %, and N/L ratio. The unexpected variation in the laboratory characteristics of patients with COVID-19 as D-dimer and CBC were normal and can't identify potential COVID-19 patients. Post-COVID sequalae (long-haulers) as chronic fatigue, polyneuropathic pains, chronic cough could happen even in patients who experienced the mild disease.

Our main recommendations are for the health system to firmly use RT-PCR to detect COVID-19 infection in addition to hematologic and biochemical parameters. We are also asking for not depending mainly on hematologic and biochemical parameters alone to detect COVID-19 or develop it. Researchers should conduct multicenter studies to elucidate the short-and long-term health effects associated with COVID-19. Our last recommendation is to encourage and facilitate COVID-19 vaccination to prevent this pandemic's spread and its related long-term complications.

Appendix 1

According to the COVID-19 protocol of the Egyptian Ministry of Health [20] , [21] , mild cases were advised for strict home isolation, received oral hydroxychloroquine 400 mg twice in the first day, then 200 mg twice for six days in addition to oral paracetamol, and multivitamins. Moderate cases required hospital admission in intermediate care. They received lopinavir/ritonavir (2 tabs 200/50) every 12 hours, oral anticoagulants, and steroids (if the patient has severe dyspnea respiratory rate >24). Severe cases were admitted in the intensive care unit (ICU) and received methylprednisolone 1-2 mg/kg/day or tocilizumab 4-8 mg/kg/dose (maximum two doses 12 to 24 hours apart after the failure of steroid therapy), enoxaparin 1 mg/kg twice daily, and remdesivr 200 mg on the first day then 100 mg daily for nine days together with other supportive and symptomatic measures. Empiric antimicrobials to treat all likely pathogens were given within one hour of ICU admission. Mechanical ventilation was needed in critically ill severe cases [20] , [21] . After hospital discharge, the mean follow-up was about 13.5 days, which changed according to the severity of the patients. 10(40%) 6(24%) 9(36%) 0.06 J o u r n a l P r e -p r o o f 

D-dimer level in COVID-19 infection: a systematic review

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain

First, second and third wave of COVID-19. What have we changed in the ICU management of these patients?

Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention

Clinical features and laboratory characteristics of patients hospitalized with COVID-19: Single centre report from Egypt

Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies

Clinical management Clinical management Living guidance COVID-19

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19 : a retrospective cohort study

How to Calculate Sample Size and Why

G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

Management Protocol for COVID-19 Patients MoHP Protocol for COVID19

Management Protocol for COVID-19 Patients Version 1.4/30th May 2020 Ministry of health and population (MOHP)

IBM SPSS Statistics for Windows

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China

Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Prognosis of COVID-19 : Changes in laboratory parameters

D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19

Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City

Hematologic parameters in patients with COVID-19 infection

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ' s public news and information

Sex and Age Differences in Telomere Length and Susceptibility to COVID-19

A Hint on the COVID-19 Risk : Population Disparities in Gene Expression of Three Receptors of SARS-CoV Address correspondence to : Guoshuai Cai Department of Environmental Health Sciences Arnold School of Public Health University of South Carolina 915 G

COVID-19 and smoking: A systematic review of the evidence

Association between laboratory parameters and CT severity in patients infected with Covid-19: A retrospective, observational study

Characteristics of Peripheral Blood Cells

Patients Revealed by a Retrospective Cohort Study

Diabetes and metabolic syndrome as risk factors for COVID-19

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Severe urticarial rash as the initial symptom of COVID-19 infection

C-reactive protein as an early predictor of COVID-19 severity

Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis